SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000890163-06-000747
Filing Date
2006-11-13
Accepted
2006-11-13 16:26:56
Documents
1
Period of Report
2006-10-31

Document Format Files

Seq Description Document Type Size
1 s11-6836_ex.html 3  
1 s11-6836_ex.xml 3 3420
  Complete submission text file 0000890163-06-000747.txt   5213
Mailing Address 1220 GLENMORE DRIVE APOPKA FL 32712
Business Address 1220 GLENMORE DRIVE APOPKA FL 32712 407-880-2213
SHEFFIELD PHARMACEUTICALS INC (Issuer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address
Business Address 210 CENTRAL PARK SOUTH NEW YORK NY 10019
KANZER STEVE H (Reporting) CIK: 0001076653 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12584 | Film No.: 061209298